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Abstract
Dysregulation of negative selection contributes to T cell-mediated autoimmunity, such as type 1 
diabetes. The events regulating thymic negative selection, however, are ill-defined. Work by our 
group and others suggest that negative selection is inefficient early in ontogeny and increases with 
age. This study examines temporal changes in negative selection and the thymic DC compartment. 
Peptide-induced thymocyte deletion in vivo was reduced in newborn versus 4 wk-old NOD mice, 
despite a similar sensitivity of the respective thymocytes to apoptosis induction. The temporal 
increase in negative selection corresponded with an elevated capacity of thymic antigen presenting 
cells to stimulate T cells, along with altered subset composition and function of resident DC. The 
frequency of SIRPα+ and plasmacytoid DC (pDC) was increased concomitant with a decrease in 
CD8α+ DC in 4 wk-old NOD thymi. Importantly, 4 wk-old versus newborn thymic SIRPα+ DC 
exhibited increased antigen processing and presentation via the MHC class II but not class I 
pathway, coupled with an enhanced T cell stimulatory capacity not seen in thymic pDC and 
CD8α+ DC. These findings indicate that the efficiency of thymic DC-mediated negative selection 
is limited early after birth, and increases with age paralleling expansion of functionally superior 
thymic SIRPα+ DC.
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Introduction
T cell central tolerance is achieved by negative selection events ongoing within the thymus. 
Single positive thymocytes (SP) in the thymic medulla undergo apoptosis or anergy upon 
relatively high avidity/affinity binding of self-peptide-MHC complexes presented by thymic 
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antigen presenting cells (APC) [1, 2]. On the other hand, aberrant thymic negative selection 
is believed to contribute to T cell-mediated autoimmune diseases such as type 1 diabetes 
(T1D) [3–6]. T1D is characterized by pathogenic CD4+ and CD8+ T cells which target 
multiple autoantigens and peptide epitopes derived from the insulin producing β cells in the 
pancreas. The events regulating the efficiency of thymic negative selection in general, and 
specifically in T1D are unclear (reviewed in [7]).
Medullary thymic epithelial cells (mTEC) and DC are major APC driving negative selection. 
mTEC are specialized APC characterized by expression of the Autoimmune regulator 
(AIRE) transcription factor, which controls expression of peripheral tissue specific antigens 
(TSA) presented to SP [8–10]. A key role for thymic DC in mediating negative selection is 
demonstrated in mice that develop T cell-mediated autoimmunity upon DC ablation [11, 12]. 
Thymic DC primarily consist of CD11c+ signal regulatory protein α+ (SIRPα+) and CD8α+ 
conventional DC (cDC) subsets as well as plasmacytoid DC (pDC) (reviewed in [13]). 
Localized to the cortico-medullary junction, DC present TSA obtained by engulfment of 
apoptotic mTEC, intercellular transfer of peptide-MHC complexes from the surface of 
mTEC, and by uptake and processing of soluble antigens (Ag) in blood [14–18]. Negative 
selection is also mediated by self-Ag laden peripheral SIRPα+ DC and pDC that migrate 
into the thymus [19–22]. Although it is widely accepted that both mTEC and thymic DC are 
critical, the relative contribution of these APC in driving negative selection remains poorly 
defined [23, 24].
Recently we showed using a thymus transplant model that development of autoreactive T 
cells in NOD mice, a model of spontaneous T1D, is restricted to a narrow window early in 
ontogeny [25]. Diabetes developed in NOD.scid recipients of thymi transplanted from 
newborn but not 4 wk-old NOD mice, indicating that the efficiency of thymic negative 
selection increases with age. Early ontogenic development of β cell-specific T cells is 
further supported by observations that NOD mice continue to develop diabetes despite 
thymectomy at 3 d of age [26]. Furthermore, observations made in other models of T cell-
mediated autoimmunity [27], and reports of autoimmunity in congenital athymic children 
receiving infant thymi transplants [28], also suggest that the efficiency of thymic negative 
selection is limited early in life. How thymic negative selection is regulated in a temporal 
manner, however, is unknown. In the current study, we demonstrate that temporal changes in 
the composition and function of thymic DC subsets, specifically within the SIRPα+ DC 
pool, parallel the increase in negative selection efficiency.
Results
In vivo induced thymic negative selection is enhanced with age in NOD mice
Inefficient thymic negative selection early after birth in NOD mice may explain the 
development of diabetes in NOD.scid mice transplanted with newborn but not 4 wk-old 
NOD thymi [25]. To test this hypothesis, sBDC mimetic peptide was administered i.v. into 
newborn and 4 wk-old NOD.BDC mice, which express the IAg7-restricted BDC2.5 
clonotypic TCR. Thymi were harvested 18 h post-injection and the frequency of apoptotic 
SP CD4+ thymocytes (CD4SP) assessed by VAD-FMK. A peptide dose-dependent increase 
in VAD-FMK+ CD4SP was seen in the thymus of 4 wk-old versus newborn NOD.BDC mice 
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(Fig. 1A,B). Consistent with this finding, sBDC-induced TCR signaling, based on the 
frequency of Nur77+ CD4SP, was also significantly increased, up to 6-fold, in 4 wk-old 
NOD.BDC mice (Fig. 1C,D). Similarly, injection of hemagglutinin (HA) peptide increased 
VAD-FMK+ CD8SP in the thymi of 4 wk-old versus newborn NOD.CL4 mice, which 
express an H2Kd-restricted, HA-specific TCR (Fig. 1E).
Previous studies have examined the sensitivity of double positive thymocytes (DP) to 
antigen-stimulated apoptosis as an additional indicator of clonal deletion efficiency [18, 29]. 
Accordingly, the frequency of sBDC-induced apoptosis of DP in NOD.BDC mice was 
measured. Similar to CD4SP, a significant increase in the percent of VAD-FMK+ DP was 
detected in 4 wk-old versus newborn thymi (Fig. 1F). Next, to determine if the temporal 
difference in peptide-induced apoptosis of thymocytes was a general observation and 
independent of the NOD genotype, C57BL/6 mice congenic for H2g7 and expressing the 
BDC2.5 TCR transgene (B6g7.BDC) were examined. Similar to NOD mice, up to a 4-fold 
increase in VAD-FMK+ DP was seen in thymi of 4 wk-old versus newborn B6g7.BDC mice 
injected with sBDC (Fig. 1G).
The limited increase in apoptotic thymocytes in newborn animals was not due to enhanced 
clearance of apoptotic cells. For example, a similar frequency of VAD-FMK+ SP was 
detected in newborn and 4 wk-old NOD animals treated with dexamethasone, which induces 
thymocyte apoptosis (Fig. 1H). Alternatively, the above age-dependent increase in thymic 
deletion may be due to elevated sensitivity of thymocytes to peptide-induced apoptosis. 
Accordingly, NOD.BDC thymocytes from newborn and 4 wk-old mice were co-cultured 
with sBDC-pulsed thymic DC from 4 wk-old NOD mice, and the frequency of VAD-FMK+ 
cells determined. Interestingly, induction of apoptosis was increased in newborn versus 4 
wk-old CD4SP at low (but not higher) sBDC concentrations (Fig. 1I). Collectively, these 
results demonstrate that peptide-induced CD4SP and CD8SP (and DP) apoptosis is 
enhanced in 4 wk-old versus newborn thymi, and independent of: i) genotype, ii) SP 
sensitivity to antigenic stimulation, and iii) apoptotic thymocyte clearance.
A temporal increase in thymic APC stimulatory capacity is due to resident DC
One scenario to explain the enhanced peptide-induced SP apoptosis in 4 wk-old animals is a 
concomitant increase in the stimulatory capacity of thymic APC. Whole thymic suspensions 
prepared from newborn and 4 wk-old NOD mice were pulsed with sBDC peptide, and co-
cultured with CFSE-labeled splenic NOD.BDC CD4+ T cells. In vitro treatment of the 
thymic suspensions ensured uniform peptide-pulsing of APC. Proliferation of CD4+ T cells 
was increased at limiting sBDC concentrations with 4 wk-old versus newborn thymic 
suspensions (Fig. 2A). Examination of the thymus cellular composition showed an increased 
frequency of thymic DC (CD11cint/hi), and an elevated ratio of thymic DC to thymocytes in 
4 wk-old versus newborn thymic suspensions (Fig. 2B,C). These results suggested that 
thymic DC contribute to the temporal increase in T cell stimulation and in turn negative 
selection efficiency. Accordingly, CD11c+ DC were depleted with magnetic beads (Fig. 2B), 
and the T cell stimulatory capacity of 4 wk-old thymus suspensions compared to 
unmanipulated thymus suspensions. DC depletion reduced CD4+ T cell proliferation in 4 
wk-old thymus suspensions, which was comparable to unmanipulated newborn thymic 
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suspensions (Fig. 2A). On the other hand, depleting DC from newborn thymic suspensions 
only minimally reduced T cell proliferation (Fig. 2A).
To directly test the stimulatory capacity of thymic DC, newborn and 4 wk-old NOD mice 
were injected with titrated doses of sBDC, and isolated thymic DC co-cultured with CFSE-
labeled NOD.BDC CD4+ T cells. CD4+ T cell proliferation was increased by thymic DC 
from 4 wk-old versus newborn mice injected with low sBDC doses (Fig. 2D). A similar 
trend of increased BDC CD4+ T cell proliferation with thymic DC isolated from 4 wk-old 
versus newborn B6g7 congenic mice injected with sBDC was also observed (Fig. 2E). 
Together these findings demonstrate that the T cell stimulatory capacity of thymic APC 
increases with age, which correlates with enhanced thymic DC function and frequency, and 
is independent of non-MHC genotype.
Thymic DC subsets exhibit distinct stimulatory capacities with age
The temporal increase in T cell stimulation by DC may be due to changes in phenotype 
and/or subset composition. Within the newborn and 4 wk-old thymic DC pools, however, no 
uniform age-dependent increase in surface expression of MHC class I and II, and co-
stimulatory molecules (CD40, CD80, CD86) was observed; in fact expression of these 
molecules tended to be increased in newborn thymic DC (Fig. 3A,B). Similar results were 
obtained for the individual DC subsets (Supporting Information Fig. 1).
Temporal changes in the composition of the 3 thymic DC subsets, namely pDC 
(CD11cintPDCA+/B220+), and conventional (CD11chi) SIRPα+ and CD8α+ DC were 
assessed. Initially, gating on the CD11cint/hi cells demonstrated distinct thymic DC 
composition in the different aged thymus (Fig. 3C); importantly, B220−SIRPα− DC 
expressed high levels of surface CD8α (Supporting Information Fig. 2). The NOD newborn 
thymus contained mostly CD8α+ DC (72.1±0.8%), whereas the remainder of the pool 
consisted of SIRPα+ DC (11.6±1.2%) and pDC (11.5±1.2%) (Fig. 3C). In 4 wk-old NOD 
thymi, however, a ≥2-fold increase in SIRPα+ DC (23.3±1.6%) and pDC (26.0±2.1%), and a 
concomitant decrease in CD8α+ DC (45.7±1.0%) was seen (Fig. 3C).
To test the stimulatory capacity of the respective thymic DC subsets, CD8α+ DC, SIRPα+ 
DC and pDC were sorted by flow cytometry from newborn and 4 wk-old NOD mice 18 h 
post-injection of sBDC, and NOD.BDC CD4+ T cell proliferation measured in vitro. Thymic 
pDC stimulated the lowest T cell proliferation, and no difference was observed between 
newborn and 4 wk-old pDC (Fig. 3D). Thymic CD8α+ DC displayed an increased capacity 
to induce CD4+ T cell proliferation relative to pDC, but again no marked difference in 
stimulatory capacity was detected between newborn and 4 wk-old CD8α+ DC (Fig. 3D). On 
the other hand, 4 wk-old versus newborn SIRPα+ DC elicited a significant increase in CD4+ 
T cell proliferation (Fig. 3D). Furthermore, T cell proliferation was increased ~2-fold by 
SIRPα+ versus CD8α+ DC from 4 wk-old thymi (Fig. 3D). These findings indicate that the 
temporal increase in frequency and stimulatory function of SIRPα+ DC contribute to the 
enhanced negative selection seen in peptide-treated 4 wk-old animals (Fig. 1).
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In vivo and in vitro Ag processing by thymic SIRPα+ DC increases with age
Thymic DC, particularly SIRPα+ DC, acquire, process and present blood borne self-Ag to 
thymocytes [16–18, 30]. With this in mind, we determined if a temporal difference existed in 
thymic DC Ag uptake, processing and presentation/stimulation. Initially, the frequency of 
fluorescent thymic DC after injection of ovalbumin Alexa Fluor 647 (OVA-647) normalized 
for body weight (e.g. 2.7 mg/kg) was assessed for newborn and 4 wk-old NOD mice. Here, 
the loss of fluorescence over time was used as a measure of OVA-647 processing [31]. A 
small fraction, ~5% and 10% of thymic pDC and CD8α+ DC, respectively, were OVA-647+ 
at 1 h post-injection, after which the frequency decreased indicating proteolytic OVA-647 
processing (Fig. 4A,B). The temporal loss of OVA-647+ pDC and CD8α+ DC was similar in 
newborn and 4 wk-old NOD mice (Fig. 4A,B). Strikingly, a 4–6-fold increase in the 
frequency of OVA-647+ for both newborn and 4 wk-old SIRPα+ DC was detected 1 h post-
injection compared to pDC and CD8α+ DC (Fig. 4A–C). Furthermore, OVA-647 was 
rapidly degraded in 4 wk-old SIRPα+ DC resulting in an ~3-fold decrease in the frequency 
of fluorescent cells over time (Fig. 4C). In contrast, OVA-647+ cells were reduced by only 
~10% for newborn SIRPα+ DC over time (Fig. 4C), indicating that in vivo exogenous Ag 
processing varies with age for thymic SIRPα+ DC.
To directly determine if differences in protein processing following Ag uptake existed, 
newborn and 4 wk-old thymic DC were co-cultured with DQ-ovalbumin (DQ-OVA) in vitro. 
Unlike OVA-647, DQ-OVA is initially non-fluorescent but upon proteolytic degradation 
emits a fluorescent signal, used to measure the efficiency of protein processing [32]. 
Consistent with the in vivo data, the frequency of DQ-OVA+ fluorescent SIRPα+ DC from 4 
wk-old versus newborn NOD mice was increased (Fig. 4F). No difference, however, was 
detected in the frequency of fluorescent thymic pDC or CD8α+ DC between newborn and 4 
wk-old NOD thymi, which in turn was reduced relative to SIRPα+ DC (Fig. 4D–F). 
Furthermore, no age-dependent differences were observed for a given DC subset regarding: 
i) mannose receptor (CD206) expression which binds to and internalizes OVA [33, 34] and 
ii) OVA-647 binding and uptake at 4° or 37° C after a 30 min incubation in vitro (data not 
shown). These results indicate that a temporal difference in Ag processing exists between 
newborn versus 4 wk-old thymic DC, which is mediated by SIRPα+ DC.
Stimulatory function of thymic SIRPα+ DC increases with age for Ag processed via the 
MHC class II but not class I pathway
Whether the enhanced Ag processing by 4 wk-old thymic DC correlates with increased T 
cell stimulation was next investigated. Newborn and 4 wk-old total thymic DC were pulsed 
with hen egg lysozyme (HEL) protein, co-cultured with Clone 4 T cells, an IAg7-restricted 
CD4+ T cell hybridoma specific for HEL11–25 [30], and IL-2 secretion measured. Consistent 
with the above OVA processing data (Fig. 4), thymic DC from 4 wk-old NOD mice induced 
significantly higher IL-2 secretion compared to newborn thymic DC (Fig. 5A). Furthermore, 
T cell stimulation was dependent on Ag processing; treatment of 4 wk-old thymic DC with a 
cocktail of protease inhibitors blocked HEL protein-induced IL-2 secretion by Clone 4 T 
cells (Fig. 5B). To determine if age-dependent changes in Ag processing and T cell 
stimulation could also be detected ex vivo, newborn and 4 wk-old NOD mice were injected 
with HEL protein and thymic DC isolated. Similar to pulsing DC with HEL protein in vitro 
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(Fig. 5A), 4 wk-old versus newborn thymic DC from HEL protein injected animals 
stimulated up to a 4-fold increase in IL-2 secretion by Clone 4 T cells (Fig. 5C,D).
Notably, the temporal increase in OVA and HEL processing by 4 wk-old thymic DC 
correlated with changes in mRNA expression of proteases associated with the MHC class II 
protein processing and presentation pathway (Fig. 5E). 4 wk-old versus newborn thymic DC 
had a 5-fold reduction in mRNA levels of the thymus specific serine protease (TSSP), and 
~3-fold increase in cathespin S (CatS) levels (Fig. 5E). H2DMα/β expression, however, was 
comparable in 4 wk-old versus newborn thymic DC (Fig. 5E). Expression of molecules 
associated with the MHC class I Ag processing and presentation pathway, including 
components of the immunoproteosome, was similar for newborn and 4 wk-old thymic DC 
(Fig. 5E). Thus, the temporal increase in CD4+ T cell stimulatory capacity of 4 wk-old 
thymic DC correlated with changes in mRNA expression of proteases associated with the 
MHC class II Ag processing and presentation pathway.
The above results for OVA processing (Fig. 4) suggested a scenario in which the increase in 
HEL-specific T cell stimulation by 4 wk-old thymic DC (Fig. 5A,C,D) was due to SIRPα+ 
DC. To test this, newborn and 4 wk-old thymic pDC, CD8α+ and SIRPα+ DC were sorted 
by flow cytometry and pulsed with 125 μg/ml HEL protein in vitro, and T cell stimulatory 
function measured. Thymic pDC induced only minimal Clone 4 T cell IL-2 secretion, 
although an increased albeit variable stimulatory capacity was seen for 4 wk-old versus 
newborn pDC (Fig. 5F,G). Thymic CD8α+ DC exhibited an increased stimulatory function 
relative to thymic pDC that was, however, similar between newborn and 4 wk-old CD8α+ 
DC (Fig. 5F,G). Notably, 4 wk-old versus newborn SIRPα+ DC induced ~3–4 fold greater 
IL-2 secretion by Clone 4 T cells (Fig. 5F,G).
We then determined if Ag cross-presentation by thymic DC also varied with age. Sorted DC 
subsets were co-cultured with HEL protein and the CD8+ T cell hybridoma Clone 8c11, 
specific for the H2Db-restricted HEL23–31 epitope. Regardless of age, pDC stimulated only 
minimal IL-2 secretion (Fig. 5H). Compared to pDC, SIRPα+ DC induced higher IL-2 
secretion but no difference between newborn and 4 wk-old SIRPα+ DC was detected (Fig. 
5H). Thymic CD8α+ DC were the most efficient at cross-presenting HEL protein, resulting 
in >5-fold increase of IL-2 secretion by Clone 8c11 T cells compared to age-matched pDC 
and SIRPα+ DC (Fig. 5H). However, no increase in IL-2 was stimulated by 4 wk-old thymic 
CD8α+ DC; in fact newborn CD8α+ DC trended towards an enhanced stimulatory capacity 
(Fig. 5H). Together these results demonstrate that increased Ag processing by 4 wk-old 
thymic DC, and specifically SIRPα+ DC, is concomitant with an increased stimulatory 
capacity of CD4+ T cells in vitro and ex vivo, not seen for cross-presented Ag.
Discussion
The goal of this work was to gain insight into the temporal events influencing the efficiency 
of thymocyte negative selection. Studies by our group and others [25, 26] indicate that the 
majority of autoreactive T cell development in NOD mice is restricted to a window early in 
ontogeny, and that the efficiency of negative selection increases with age. The current study 
provides further support for this model. Peptide-induced apoptosis of SP and DP was 
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reduced in newborn mice relative to 4 wk-old animals (Fig. 1). Age-dependent differences in 
the efficiency of negative selection were also detected in B6g7.BDC mice (Fig. 1) 
demonstrating that these changes are not unique to the NOD genotype. Indeed inefficient 
negative selection early in ontogeny has been reported in B6 mice expressing a transgenic 
myelin basic protein-specific TCR [27].
How then is thymic negative selection regulated in an age-dependent manner? Our results 
rule out a temporal increase in the sensitivity of SP to apoptosis induced in an antigen-
independent (Fig. 1H) and dependent (Fig. 1I) manner, as well as differences in thymic 
clearance of apoptotic thymocytes (Fig. 1H). Indeed, SP from 4 wk-old NOD mice had no 
increase in surface expression of pro-apoptotic molecules such as PD-1/PD-L1 and Fas/FasL 
(data not shown). Our findings implicate temporal changes within the thymic DC pool. Four 
wk-old versus newborn NOD thymus suspensions induced greater T cell proliferation (Fig. 
2A) which: i) correlated with an increased frequency of thymic DC (Fig. 2B,C), and ii) was 
reduced by DC depletion (Fig. 2A). Furthermore, thymic DC isolated from 4 wk-old NOD 
mice injected with peptide (Fig. 2D) or intact Ag (Fig. 5C,D) stimulated increased T cell 
proliferation or IL-2 production compared to newborn thymic DC. A previous study showed 
that Ag injected i.v. is captured and presented in vivo by thymic DC, and not mTEC [16]. 
Therefore under our experimental conditions, mTEC are expected to have a limited role. Our 
results, however, do not exclude the possibility that changes within mTEC or other thymic 
APC, such B cells and macrophages, also impact the efficiency of thymic negative selection 
in a temporal manner.
Marked temporal differences in the frequency and function were detected among the thymic 
DC subsets. The newborn thymus consisted mostly of CD8α+ DC (~70%), whereas the 
frequency of both SIRPα+ DC and pDC increased with age (Fig. 3C). This profile likely 
reflects the thymic origin of CD8α+ DC and the recruitment of migratory SIRPα+ DC and 
pDC from the periphery. An earlier study also reported a temporal increase in thymic pDC 
[35]. Under the conditions tested a hierarchy in T cell stimulatory capacity was seen among 
the thymic DC subsets from Ag-injected animals, which was age-dependent. Sorted thymic 
pDC from peptide-injected mice or pulsed with intact Ag in vitro were the least stimulatory 
(Figs. 3D, 5) and expressed the lowest levels of MHC and co-stimulatory molecules (e.g. 
CD40, CD80, CD86) among the 3 thymic DC subsets (Supporting Information Fig. 1). 
Thymic CD8α+ DC stimulated T cells to a greater extent but neither CD8α+ DC nor pDC 
showed increased stimulatory activity with age. Newborn thymic SIRPα+ DC exhibited 
comparable stimulatory activity to either newborn or 4 wk-old CD8α+ DC (Figs. 3D, 5). 
However, the stimulatory capacity of 4 wk-old thymic SIRPα+ DC was increased relative to 
newborn SIRPα+ DC and 4 wk-old CD8α+ DC (and pDC) (Figs. 3D, 5F,G). Our findings 
support a scenario in which the temporal increase in the frequency and stimulatory activity 
of SIRPα+ DC contribute to enhanced negative selection. Reduced peptide-induced 
apoptosis of thymocytes has been reported in CCR2 knockout mice, which have a decreased 
frequency of thymic SIRPα+ DC, further supporting a key role for this thymic DC subset in 
negative selection [18].
Intrinsic and extrinsic factors likely contribute to the enhanced stimulatory function of 
SIRPα+ DC over time. The latter, however, was independent of any marked increase in 
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surface expression of MHC class I and II, as well as the co-stimulatory molecules CD40, 
CD80, and CD86 on 4 wk-old versus newborn thymic SIRPα+ or CD8α+ DC (Supporting 
Information Fig. 1). However, the possibility that expression of other costimulatory 
molecules may vary temporally and contribute to changes in the stimulatory capacity of 
SIRPα+ DC cannot be ruled out. Notably, SIRPα+ DC in adult mice are localized next to 
blood vessels at the cortico-medullary junction and within the medulla, which is expected to 
enhance capture of blood borne Ag [18] such as OVA-647 and HEL. Indeed, a 4–6-fold 
increase in the frequency of fluorescent SIRPα+ DC was detected in newborn and 4 wk-old 
NOD mice relative to CD8α+ DC and pDC shortly after OVA-647 injection (Fig. 4A–C). 
Differences in circulating Ag uptake or presentation among thymic SIRPα+ DC, CD8α+ DC 
and pDC have also been reported [16–18].
Strikingly, an age-dependent increase in Ag processing was also seen for thymic SIRPα+ 
DC but not other DC subsets. Processing of OVA-647 and DQ-OVA in vivo and in vitro was 
increased in 4 wk-old versus newborn SIRPα+ DC (Fig. 4C,F), whereas age-dependent 
differences among thymic CD8α+ DC and pDC were only minimal. This increased Ag 
processing activity correlated with enhanced CD4+ T cell stimulation (Fig. 5F,G). 
Interestingly, temporal differences in mRNA expression were detected in thymic DC for 
molecules associated with MHC class II but not class I Ag processing and presentation (Fig. 
5E). Decreased TSSP expression, coupled with an increase in expression of CatS would be 
expected to elevate the stimulatory capacity of 4 wk-old thymic DC, and the efficiency of 
negative selection (Fig. 5E). For example, TSSP expressed by thymic DC has been shown to 
limit presentation of certain β cell-derived peptides, and TSSP deficiency enhances negative 
selection in transgenic NOD thymocytes depending on the epitopes recognized by β cell-
specific TCR [37]. Furthermore, β cell autoimmunity is blocked in NOD mice lacking TSSP 
expression [6, 37, 38]. Elevated expression of CatS, which drives the proteolytic degradation 
of the invariant chain [39–43] would be predicted to increase the number of “empty” MHC 
class II complexes, and improve the loading of self-peptides by 4 wk-old thymic DC. 
Altered expression of various components of the MHC II Ag processing machinery is 
expected to have both quantitative and qualitative effects on the presentation of 
autoantigenic peptide-MHC complexes that influence the efficiency of negative selection of 
self-specific CD4SP clonotypes. Additional experiments are needed to better define how 
temporal differences in TSSP and CatS influence thymic DC Ag presentation.
Multiple parameters, including an altered thymic SIRPα+ DC pool, are expected to 
contribute to the age-dependent increase in negative selection. For instance, the structural 
organization of the thymus undergoes marked changes with age that likely impact the 
efficacy of negative selection [25]. By 4 wk of age, the murine thymus contains large, well-
formed medulla regions. In contrast, the newborn thymic architecture consists of small 
poorly defined medulla with small clusters of mTEC and DC, which may limit dwell times 
and the avidity of interactions between thymic APC and SP. Ontogenic changes in mTEC, 
such as increases in the frequency of mature mTEC and/or expression of TSA may also 
promote increased negative selection. For example, AIRE expression by mTEC is critical 
early but not later in ontogeny to prevent autoimmunity [44]. Concomitant changes in APC 
function for thymic DC and mTEC may reflect a “division of labor” [45]. Here mTEC drive 
negative selection via expression and presentation of TSA whereas thymic DC, particularly 
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SIRPα+ DC, promote negative selection to self-Ag captured from blood or ferried from the 
periphery. Similarly, the respective thymic DC subsets may have specialized roles in 
mediating negative selection and/or promoting Foxp3+Treg development, which in turn 
depend on how self-Ag is acquired [16, 17]. An increased capacity to capture soluble Ag 
(e.g. SIRPα+ DC), acquire peptide-MHC complexes from the surface of mTEC, and/or 
uptake of apoptotic mTEC may favor a given thymic DC subset. Indeed, thymic CD8α+ DC 
demonstrated increased cross-presentation of exogenous Ag to CD8+ T cells relative to 
SIRPα+ DC and pDC (Fig. 5H) similar to peripheral CD8α+ DC [46]. Interestingly, the 
efficiency of cross-presentation was not significantly affected by age, consistent with the 
lack of age-dependent changes in gene expression of MHC class I processing molecules 
(Fig. 5E). The latter further highlights the selectivity of the ontogenic changes within thymic 
SIRPα+ DC. Additional studies are needed to define the basis for the temporal increase in 
Ag processing and presentation by SIRPα+ DC. It is possible that expression of local or 
“licensing” factors [47] that promote enhanced Ag processing by thymic SIRPα+ DC are 
increased in an age-dependent manner.
These results provide novel insight into the temporal regulation of negative selection. Our 
findings demonstrate that the age-dependent increase in the efficiency of negative selection 
is in part attributed to quantitative and qualitative changes within the thymic SIRPα+ DC 
pool. We propose a model in which efficacy of negative selection in the thymus early after 
birth is enhanced by an increase in thymic SIRPα+ DC which traffic from the periphery and 
localize to blood vessels within the cortico-medullary junction and medulla. This positioning 
facilitates efficient sampling of blood borne self-Ag, which coupled with a temporal increase 
in Ag processing and presentation, leads to enhanced negative selection of SP. These 
observations underscore the complex and dynamic nature of T cell central tolerance.
Materials and Methods
Mice and cell lines
NOD/LtJ (NOD), C57BL/6.H2g7 (B6g7), NOD.Cg-Tg(TcraBDC2.5)1Doi 
Tg(TcrbBDC2.5)2Doi/DoiJ (NOD.BDC), and NOD.Cg-Thy1a/Thy1b Tg(TcraCl4, 
TcrbCl4)1Shrm/ShrmJ (NOD.CL4) mice were bred and maintained in specific pathogen-
free facilities at the University of North Carolina at Chapel Hill (UNC-CH). B6g7 and 
B6g7.BDC mice were a kind gift from Drs. Mathis and Benoist. Mouse experiments were 
approved by the UNC-CH Institutional Animal Care and Use Committee. Clone 4 and Clone 
8c11 T cell hybridomas were a kind gift from Dr. Unanue [30].
Flow cytometry
All Ab were purchased from eBioscience, BD Biosciences, or Biolegend. Staining was 
measured with a Beckman-Coulter Cyan (Dako) or BD LSR II, and results analyzed with 
Summit (Dako) or FlowJo software. Cells were stained with Pacific Orange succinimidyl 
ester (Invitrogen), LIVE/DEAD fixable blue dead cell stain (Invitrogen) or 7AAD (BD 
Biosciences) to exclude dead cells. For analyses of DC subsets, live cells were gated on and 
autofluorescent cells excluded in a dump channel. pDC were identified as CD11cint (N418), 
B220+ (RA3-6B2)/PDCA+ (927) or CD45RA+ (14.8). cDC were identified as CD11chi and 
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separated based on SIRPα (P84) and CD8α (53-6.7) expression. SIRPα+ DC were 
identified as CD11chi SIRPα+, whereas CD8α+ DC were classified as CD11chiSIRPα−/
CD8α+.
Thymocyte negative selection assays
Newborn and 4 wk-old NOD.BDC or NOD.CL4 mice were injected i.v. with peptide via the 
percutaneous vein [48] or lateral tail vein, and 18 h later single cell thymus suspensions 
prepared. To measure apoptosis, thymocytes were stained with CaspACE FITC-VAD-FMK 
(Promega) or anti-Nur77 (12.14), and CD4 (RMA4-4), –CD8α and –CD69 (H1.2F3) Ab. 
Anti-Vβ4 (KT4) and -Vβ8.1/8.2 (MR5-2) Ab were used to identify clonotypic BDC and 
CL4 thymocytes, respectively. Thymocytes were fixed/permeabilized for intracellular 
Nur77staining. For in vitro negative selection assays, bulk thymic DC (2×104) isolated from 
4 wk-old donors (see below) were pulsed with sBDC for 1 h, washed, co-cultured with 
NOD.BDC newborn or 4 wk-old thymocytes (2×105) for 6 h at 37°C, and thymocyte 
apoptosis measured via flow cytometry.
Thymic DC isolation and analyses
Newborn and 4 wk-old thymi were digested with collagenase D (0.5 mg/mL) and DNase I (5 
μg/mL; Roche) for 30 min at 37°C, and total thymic DC isolated using anti-CD11c magnetic 
beads (Miltenyi Biotech) as per the manufacturer’s directions; DC purity was typically 
~90%. Alternatively, thymic DC subsets defined as above were sorted by flow cytometry 
using a Beckman-Coulter MoFlo (Dako) or FACsAria III (BD Bioscience). DC maturation 
was assessed with Ab specific for CD40 (3/23), CD80 (16–10A1), CD86 (GL1), H2Kd 
(SF1–1.1), H2Db (KH95), and IAg7 (10-3.6). In some experiments, thymic DC were isolated 
18 h post i.v. injection of 10–250 μg sBDC peptide/mouse. To assess T cell stimulatory 
capacity, isolated DC were co-cultured at a 1:10 ratio with splenic BDC CD4+ T cells 
purified with a CD4+ T cell isolation kit (Miltenyi Biotech), and labeled with CFSE 
(Invitrogen). After 72 h, cells were stained with Pacific Orange live/dead cell marker, anti-
CD4, -CD3 and -Vβ4, and proliferation measured by flow cytometry. Thymus suspensions, 
either unmanipulated or depleted of DC using anti-CD11c magnetic beads, were pulsed with 
sBDC, and co-cultured with CFSE-labeled splenic BDC CD4+ T cells at a 1:10 ratio for 72 
h.
Analyses of thymic DC Ag processing
OVA processing—Newborn and 4 wk-old NOD mice were injected i.v. with 2.7 mg/kg 
body weight (3.5 and 50 μg, respectively) of OVA-647 (Invitrogen), and OVA-647+ thymic 
DC analyzed by flow cytometry. In addition, purified thymic DC (2.5–5×104) were cultured 
with 0.5 μg/well of DQ-OVA (Invitrogen), and analyzed by flow cytometry.
HEL processing—Newborn and 4 wk-old NOD mice were injected with 2.7 or 27 mg/kg 
body weight of HEL protein (Sigma), respectively, and thymic DC isolated 30 min later by 
anti-CD11c magnetic beads. Alternatively, total thymic DC or sorted thymic DC subsets 
were: i) incubated with HEL protein for 30 min at 37°C, washed and co-cultured at a 1:1 
ratio with Clone 4 CD4+ T cells in the presence or absence of a protease inhibitor cocktail 
(Sigma), or ii) co-cultured with HEL protein and at a 1:1 ratio with Clone 8c11 CD8+ T cells 
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for up 48 h. IL-2 secretion by Clone 4 or 8c11 T cells was then measured by ELISA as 
described [49].
Real-time PCR
NOD newborn and 4 wk-old thymic DC were enriched using anti-CD11c beads and RNA 
isolated with a Qiagen RNAeasy kit followed by cDNA synthesis. 100–200 ng of cDNA was 
utilized in real-time PCR reactions. Primer sequences are provided in Supporting 
Information Table 1. The fold increase in RNA expression levels of 4 wk-old over newborn 
thymic DC was calculated using the 2 (−ΔΔCt) method with β actin as the housekeeping 
reference gene.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
AIRE autoimmune regulator
Ag antigen
APC antigen presenting cells
CFSE carboxyfluorescein diacetate succinmidyl ester
CatS cathespin S, (c/p)DC, (conventional/plasmacytoid) dendritic cell
DP double-positive thymocyte
HA influenza hemagglutinin peptide
HEL hen egg lysozyme
OVA ovalbumin
SIRPα signal regulatory protein alpha
SP single-positive thymocyte
(m/c)TEC (medullary/cortical) thymic epithelial cell
TSA tissue-specific Ag
TSSP thymus specific serine protease
T1D type 1 diabetes
Kroger et al. Page 11
Eur J Immunol. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
References
1. Kyewski B, Klein L. A central role for central tolerance. Annu Rev Immunol. 2006; 24:571–606. 
[PubMed: 16551260] 
2. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the 
thymus. Nature. 1994; 372:100–103. [PubMed: 7969401] 
3. Kishimoto H, Sprent J. A defect in central tolerance in NOD mice. Nat Immunol. 2001; 2:1025–
1031. [PubMed: 11668341] 
4. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, 
Eisenbarth GS, Bennett ST, Patel DD. The insulin gene is transcribed in the human thymus and 
transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus 
for type 1 diabetes. Nat Genet. 1997; 15:293–297. [PubMed: 9054945] 
5. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, 
Polychronakos C. Insulin expression in human thymus is modulated by INS VNTR alleles at the 
IDDM2 locus. Nat Genet. 1997; 15:289–292. [PubMed: 9054944] 
6. Serre L, Fazilleau N, Guerder S. Central tolerance spares the private high-avidity CD4 T-cell 
repertoire specific for an islet antigen in NOD mice. Eur J Immunol. 2015
7. Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev 
Immunol. 2005; 23:447–485. [PubMed: 15771578] 
8. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic 
epithelial cells mirrors the peripheral self. Nat Immunol. 2001; 2:1032–1039. [PubMed: 11600886] 
9. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, 
Dierich A, Benoist C, Mathis D. Projection of an immunological self shadow within the thymus by 
the aire protein. Science. 2002; 298:1395–1401. [PubMed: 12376594] 
10. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of 
organ-specific T cells. Nat Immunol. 2003; 4:350–354. [PubMed: 12612579] 
11. Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, Brocker T, Voehringer D. Constitutive 
ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal 
autoimmunity. J Exp Med. 2009; 206:549–559. [PubMed: 19237601] 
12. Kaneko T, Saito Y, Kotani T, Okazawa H, Iwamura H, Sato-Hashimoto M, Kanazawa Y, Takahashi 
S, Hiromura K, Kusakari S, Kaneko Y, Murata Y, Ohnishi H, Nojima Y, Takagishi K, Matozaki T. 
Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell 
differentiation and induces autoimmunity. J Immunol. 2012; 188:5397–5407. [PubMed: 
22539788] 
13. Wu L, Shortman K. Heterogeneity of thymic dendritic cells. Semin Immunol. 2005; 17:304–312. 
[PubMed: 15946853] 
14. Koble C, Kyewski B. The thymic medulla: a unique microenvironment for intercellular self-antigen 
transfer. J Exp Med. 2009; 206:1505–1513. [PubMed: 19564355] 
15. Hubert FX, Kinkel SA, Davey GM, Phipson B, Mueller SN, Liston A, Proietto AI, Cannon PZ, 
Forehan S, Smyth GK, Wu L, Goodnow CC, Carbone FR, Scott HS, Heath WR. Aire regulates the 
transfer of antigen from mTECs to dendritic cells for induction of thymic tolerance. Blood. 2011; 
118:2462–2472. [PubMed: 21505196] 
16. Atibalentja DF, Byersdorfer CA, Unanue ER. Thymus-blood protein interactions are highly 
effective in negative selection and regulatory T cell induction. J Immunol. 2009; 183:7909–7918. 
[PubMed: 19933868] 
17. Atibalentja DF, Murphy KM, Unanue ER. Functional redundancy between thymic CD8alpha+ and 
Sirpalpha+ conventional dendritic cells in presentation of blood-derived lysozyme by MHC class 
II proteins. J Immunol. 2011; 186:1421–1431. [PubMed: 21178002] 
18. Baba T, Nakamoto Y, Mukaida N. Crucial contribution of thymic Sirp alpha+ conventional 
dendritic cells to central tolerance against blood-borne antigens in a CCR2-dependent manner. J 
Immunol. 2009; 183:3053–3063. [PubMed: 19675159] 
19. Li J, Park J, Foss D, Goldschneider I. Thymus-homing peripheral dendritic cells constitute two of 
the three major subsets of dendritic cells in the steady-state thymus. J Exp Med. 2009; 206:607–
622. [PubMed: 19273629] 
Kroger et al. Page 12
Eur J Immunol. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
20. Proietto AI, van Dommelen S, Zhou P, Rizzitelli A, D’Amico A, Steptoe RJ, Naik SH, Lahoud 
MH, Liu Y, Zheng P, Shortman K, Wu L. Dendritic cells in the thymus contribute to T-regulatory 
cell induction. Proc Natl Acad Sci U S A. 2008; 105:19869–19874. [PubMed: 19073916] 
21. Bonasio R, Scimone ML, Schaerli P, Grabie N, Lichtman AH, von Andrian UH. Clonal deletion of 
thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol. 2006; 7:1092–
1100. [PubMed: 16951687] 
22. Hadeiba H, Lahl K, Edalati A, Oderup C, Habtezion A, Pachynski R, Nguyen L, Ghodsi A, Adler 
S, Butcher EC. Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote 
central tolerance. Immunity. 2012; 36:438–450. [PubMed: 22444632] 
23. Klein L, Hinterberger M, von Rohrscheidt J, Aichinger M. Autonomous versus dendritic cell-
dependent contributions of medullary thymic epithelial cells to central tolerance. Trends Immunol. 
2011; 32:188–193. [PubMed: 21493141] 
24. Gallegos AM, Bevan MJ. Central tolerance to tissue-specific antigens mediated by direct and 
indirect antigen presentation. J Exp Med. 2004; 200:1039–1049. [PubMed: 15492126] 
25. He Q, Morillon YM 2nd, Spidale NA, Kroger CJ, Liu B, Sartor RB, Wang B, Tisch R. Thymic 
development of autoreactive T cells in NOD mice is regulated in an age-dependent manner. J 
Immunol. 2013; 191:5858–5866. [PubMed: 24198282] 
26. Gagnerault MC, Lanvin O, Pasquier V, Garcia C, Damotte D, Lucas B, Lepault F. Autoimmunity 
during thymectomy-induced lymphopenia: role of thymus ablation and initial effector T cell 
activation timing in nonobese diabetic mice. J Immunol. 2009; 183:4913–4920. [PubMed: 
19801516] 
27. Huseby ES, Sather B, Huseby PG, Goverman J. Age-dependent T cell tolerance and autoimmunity 
to myelin basic protein. Immunity. 2001; 14:471–481. [PubMed: 11336692] 
28. Markert ML, Devlin BH, McCarthy EA. Thymus transplantation. Clin Immunol. 2010; 135:236–
246. [PubMed: 20236866] 
29. Zucchelli S, Holler P, Yamagata T, Roy M, Benoist C, Mathis D. Defective central tolerance 
induction in NOD mice: genomics and genetics. Immunity. 2005; 22:385–396. [PubMed: 
15780994] 
30. Belizaire R, Unanue ER. Targeting proteins to distinct subcellular compartments reveals unique 
requirements for MHC class I and II presentation. Proc Natl Acad Sci U S A. 2009; 106:17463–
17468. [PubMed: 19805168] 
31. Schurich A, Bottcher JP, Burgdorf S, Penzler P, Hegenbarth S, Kern M, Dolf A, Endl E, Schultze J, 
Wiertz E, Stabenow D, Kurts C, Knolle P. Distinct kinetics and dynamics of cross-presentation in 
liver sinusoidal endothelial cells compared to dendritic cells. Hepatology. 2009; 50:909–919. 
[PubMed: 19610048] 
32. Daro E, Pulendran B, Brasel K, Teepe M, Pettit D, Lynch DH, Vremec D, Robb L, Shortman K, 
McKenna HJ, Maliszewski CR, Maraskovsky E. Polyethylene glycol-modified GM-CSF expands 
CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a 
comparative analysis with Flt3 ligand. J Immunol. 2000; 165:49–58. [PubMed: 10861034] 
33. Janicka M, Chindemi PA, Hu WL, Regoeczi E. Effect of transferrin on the degradation of 
glycoproteins bearing a hybrid or high-mannose glycan by alveolar macrophages. Exp Cell Res. 
1994; 215:17–22. [PubMed: 7957665] 
34. Burgdorf S, Kautz A, Bohnert V, Knolle PA, Kurts C. Distinct pathways of antigen uptake and 
intracellular routing in CD4 and CD8 T cell activation. Science. 2007; 316:612–616. [PubMed: 
17463291] 
35. Dakic A, Shao QX, D’Amico A, O’Keeffe M, Chen WF, Shortman K, Wu L. Development of the 
dendritic cell system during mouse ontogeny. J Immunol. 2004; 172:1018–1027. [PubMed: 
14707075] 
36. Spidale NA, Wang B, Tisch R. Cutting edge: Antigen-specific thymocyte feedback regulates 
homeostatic thymic conventional dendritic cell maturation. J Immunol. 2014; 193:21–25. 
[PubMed: 24890722] 
37. Viret C, Mahiddine K, Baker RL, Haskins K, Guerder S. The T Cell Repertoire-Diversifying 
Enzyme TSSP Contributes to Thymic Selection of Diabetogenic CD4 T Cell Specificities Reactive 
to ChgA and IAPP Autoantigens. J Immunol. 2015; 195:1964–1973. [PubMed: 26209627] 
Kroger et al. Page 13
Eur J Immunol. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
38. Viret C, Leung-Theung-Long S, Serre L, Lamare C, Vignali DA, Malissen B, Carrier A, Guerder S. 
Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune 
diabetes in mice. J Clin Invest. 2011; 121:1810–1821. [PubMed: 21505262] 
39. Driessen C, Bryant RA, Lennon-Dumenil AM, Villadangos JA, Bryant PW, Shi GP, Chapman HA, 
Ploegh HL. Cathepsin S controls the trafficking and maturation of MHC class II molecules in 
dendritic cells. J Cell Biol. 1999; 147:775–790. [PubMed: 10562280] 
40. Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD, Eastman 
SE, Howard ED, Clarke SR, Rosloniec EF, Elliott EA, Rudensky AY. Impaired invariant chain 
degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null 
mice. Immunity. 1999; 10:207–217. [PubMed: 10072073] 
41. Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ, Riese R, Ploegh HL, Chapman HA. 
Cathepsin S required for normal MHC class II peptide loading and germinal center development. 
Immunity. 1999; 10:197–206. [PubMed: 10072072] 
42. Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, 
Chapman HA. Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest. 
1998; 101:2351–2363. [PubMed: 9616206] 
43. Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA. Essential 
role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. 
Immunity. 1996; 4:357–366. [PubMed: 8612130] 
44. Guerau-de-Arellano M, Martinic M, Benoist C, Mathis D. Neonatal tolerance revisited: a perinatal 
window for Aire control of autoimmunity. J Exp Med. 2009; 206:1245–1252. [PubMed: 
19487417] 
45. Klein L, Kyewski B. Self-antigen presentation by thymic stromal cells: a subtle division of labor. 
Curr Opin Immunol. 2000; 12:179–186. [PubMed: 10712940] 
46. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S, Cheong C, 
Liu K, Lee HW, Park CG, Steinman RM, Nussenzweig MC. Differential antigen processing by 
dendritic cell subsets in vivo. Science. 2007; 315:107–111. [PubMed: 17204652] 
47. Dresch C, Ackermann M, Vogt B, de Andrade Pereira B, Shortman K, Fraefel C. Thymic but not 
splenic CD8(+) DCs can efficiently cross-prime T cells in the absence of licensing factors. Eur J 
Immunol. 2011; 41:2544–2555. [PubMed: 21748731] 
48. Sands MS, Barker JE. Percutaneous intravenous injection in neonatal mice. Lab Anim Sci. 1999; 
49:328–330. [PubMed: 10403452] 
49. Johnson MC, Garland AL, Nicolson SC, Li C, Samulski RJ, Wang B, Tisch R. beta-cell-specific 
IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice. Diabetes. 
2013; 62:3775–3784. [PubMed: 23884888] 
Kroger et al. Page 14
Eur J Immunol. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. The efficiency of peptide-induced negative selection increases with age
Newborn and 4 wk-old (A–D) NOD.BDC, mice were injected i.v. with sBDC peptide and 
the frequency of (A,B) VAD-FMK+ and (C,D) Nur77+ CD4SP thymocytes determined via 
flow cytometry. (D) The fold increase in Nur77+ CD4SP of sBDC-treated versus untreated 4 
wk-old and newborn animals. (A,B) Data ± SEM are the average of ≥3 separate 
experiments, with ≥4 mice/peptide dose; *p<0.05 (paired Student’s t-test). (C,D) Data ± 
SEM are the average of 2 separate experiments, n≥6 mice/group; *p<0.05 (paired Student’s 
t-test). (E) NOD.CL4 newborn and 4 wk-old mice were injected i.v. with HA peptide and the 
frequency of VAD-FMK+ CD8SP thymocytes determined via flow cytometry. Data ± SEM 
are the average of ≥3 separate experiments with 3 untreated mice and ≥ 5 mice/peptide dose; 
*p<0.05 (paired Student’s t-test). (F) NOD.BDC and (G) B6g7.BDC newborn and 4 wk-old 
mice were injected with sBDC peptide i.v., and the percent of VAD-FMK+ DP detected by 
flow cytometry. Data ± SEM are the average of ≥3 separate experiments, with ≥4 NOD and 
6 B6g7.BDC mice per group tested; *p<0.05 (paired Student’s t-test). (H) Frequency of 
VAD-FMK+ SP in NOD newborn or 4 wk-old mice injected with 12.5 mg/kg of 
dexamethasone measured by flow cytometry; the data ± SEM are the average of 2 separate 
experiments analyzing ≥5 animals (*,# p<0.05 Student’s t-test for CD4 and CD8SP, 
respectively). (I) In vitro peptide-induced apoptosis in NOD.BDC newborn and 4 wk-old 
thymocytes was determined via flow cytometry. Data ± SEM are the average of ≥3 separate 
experiments examining ≥9 mice; *p<0.05 (paired Student’s t-test).
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Figure 2. Thymic DC stimulatory capacity increases in a temporal manner
(A) CFSE-labeled NOD.BDC CD4+ T cells were co-cultured with sBDC pulsed NOD 
newborn or 4 wk-old thymus cell suspensions ± CD11c+ cells at a 1:10 cell ratio (n=6–8 
mice). *p<0.05 (paired Student’s t test), total newborn versus 4 wk-old peptide pulsed 
thymic suspensions; #/^p<0.05 (paired Student’s t test) total 4 wk-old versus DC-depleted 4 
wk-old and newborn peptide pulsed thymic suspensions, respectively. (B) DC frequency in 
NOD newborn and 4 wk-old thymus suspensions prior to and after anti-CD11c bead 
depletion; data are representative of 3 separate experiments. (C) DC frequency and the ratio 
of DC to thymocytes in newborn and 4 wk-old thymi (n≥10 mice/group). (D) T cell 
proliferation induced by thymic DC isolated from NOD mice injected with sBDC or left 
untreated, and co-cultured with CFSE-labeled NOD.BDC CD4+ T cells. Data ± SEM are the 
average of 4 separate experiments. *p<0.05 (paired Student’s t-test). (E) T cell stimulatory 
capacity of newborn and 4 wk-old bulk thymic DC isolated from B6g7 mice injected with 
different doses of sBDC peptide, and cultured with CFSE-labeled NOD.BDC CD4+ T cells 
(n=2–3 mice/group).
Kroger et al. Page 16
Eur J Immunol. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. SIRPα+ DC are increased in the 4 wk-old thymus and exhibit enhanced T cell 
stimulatory capacity
Expression of (A) co-stimulatory and (B) MHC molecules by NOD newborn and 4 wk-old 
thymic DC; data ± SEM are the average of ≥4 separate experiments. (C) Frequency of NOD 
newborn and 4 wk-old thymic DC subsets (n=7 mice). (D) T cell stimulation by newborn 
versus 4 wk-old thymic DC subsets sorted from NOD mice, injected with 10 μg sBDC, and 
cultured with CFSE-labeled NOD.BDC CD4+ T cells; data ± SEM are the average of 12 
separate samples. *p<0.05 (paired Student’s t-test).
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Figure 4. 4 wk-old thymic SIRPα+ DC exhibit enhanced antigen processing and presentation 
properties
Percent of OVA-647+ thymic (A) pDC, (B) CD8α+, and (C) SIRPα+ from newborn or 4 wk-
old NOD mice injected with 2.7 mg/kg (3.5 μg or 50 μg respectively) of OVA-647 (n≥ 8 
mice/group) at different times post injection. (D–F) Frequency of fluorescent thymic DC 
from newborn and 4 wk-old NOD mice treated with 0.5 μg/well DQ-OVA in vitro. Data ± 
SEM are the average of 4 separate experiments. *p<0.05 (A–C, Student’s t-test; D–F, linear 
regression analysis).
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Figure 5. 4 wk-old SIRPα+ DC demonstrate enhanced Ag processing and T cell stimulation
Newborn and 4 wk-old NOD thymic DC (A–E) in bulk or (F–H) flow-sorted subsets were 
tested for inducing IL-2 secretion by (A–D, F, G) Clone 4 CD4+ or (H) 8c11 CD8+ HEL-
specific T cells. (A,B, F–H) Thymic DC were pulsed with (A,B) varying concentrations, 
(F,G) 125 μg/ml, or (H) 500 μg/ml of HEL protein in vitro, or (C,D) isolated from newborn 
and 4 wk-old NOD mice injected i.v. with 2.7 or 27 mg/kg body weight of HEL, 
respectively. (B) IL-2 induced secretion following pre-treatment of NOD 4 wk-old thymic 
DC with a protease inhibitor cocktail. (D,G) Fold increase in IL-2 production induced by 4 
wk-old versus newborn thymic DC with the newborn values equal to 1. (E) Relative 
expression of MHC I and II protein processing molecules in NOD newborn and 4 wk-old 
thymic DC determined by real-time PCR. (H) Sorted thymic DC subsets were co-cultured 
with 500 μg/mL HEL protein plus Clone 8c11 CD8+ T cells and IL-2 measured. Data ± 
SEM of n=2 (B,F,G), n=3 (A,C,D,H), n=4–5 (E) separate experiments are depicted. *p<0.05 
(Student’s paired t-test).
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